Scarica l'app Stockscreener
10.50
0.28%
-0.03
Dopo l'orario di chiusura:
10.50
Precedente Chiudi:
$10.53
Aprire:
$10.102
Volume 24 ore:
1,218
Relative Volume:
0.17
Capitalizzazione di mercato:
$61.30M
Reddito:
$503.40K
Utile/perdita netta:
$9.17M
Rapporto P/E:
5.7982
EPS:
1.8109
Flusso di cassa netto:
$-604.40K
1 W Prestazione:
+1.99%
1M Prestazione:
-0.94%
6M Prestazione:
-26.32%
1 anno Prestazione:
+6.49%
Intervallo 1D:
$10.05
$10.50
Intervallo di 1 settimana:
$10.05
$10.53
Portata 52W:
$8.56
$14.76
Daxor Corporation Stock (DXR) Company Profile
Nome
Daxor Corporation
Settore
Industria
Telefono
212-330-8500
Indirizzo
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR vs ISRG, BDX, MDLN, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
10.50 | 61.48M | 503.40K | 9.17M | -604.40K | 1.8109 |
ISRG
Intuitive Surgical Inc
|
427.30 | 153.29B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
156.30 | 42.86B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
43.01 | 36.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
66.87 | 33.32B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.75 | 31.68B | 5.54B | 1.52B | 1.74B | 10.37 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-05-16 | Iniziato | Ascendiant Capital Markets | Buy |
Daxor Corporation Borsa (DXR) Ultime notizie
Daxor to exhibit blood volume analyzer at dysautonomia conference By Investing.com - Investing.com Canada
Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas - The Manila Times
Daxor debuts Blood Volume Analyzer at dysautonomia conference - Stock Titan
DXRDaxor Corp Options - Finviz
Avoiding Lag: Real-Time Signals in (DXR) Movement - Stock Traders Daily
Daxor Corporation (DXR) Edges Higher, Testing Key Resistance ZoneAdvance Decline Volume - dars.gov.et
Enterprise value to EBITDA forward of Daxor Corporation – NASDAQ:DXR - TradingView
Price to sales forward of Daxor Corporation – FWB:DX5 - TradingView
Price to book forward of Daxor Corporation – FWB:DX5 - TradingView
Enterprise value to revenue forward of Daxor Corporation – NASDAQ:DXR - TradingView
Enterprise value to EBIT forward of Daxor Corporation – NASDAQ:DXR - TradingView
Price to earnings forward of Daxor Corporation – NASDAQ:DXR - TradingView
Enterprise value to EBITDA forward of Daxor Corporation – FWB:DX5 - TradingView
Daxor Corporation (DXR) Edges Lower, Testing Support Levels Near $10.25Market Profile - dars.gov.et
DX5 Forecast — Price Target — Prediction for 2027 - TradingView
Daxor Corporation Actuals & Estimates (NASDAQ:DXR) - TradingView
DXR Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Daxor Corp For: 25 June By Investing.com - Investing.com South Africa
Daxor (DXR) CFO receives 12,000-share stock grant, now holds 33,050 - Stock Titan
DAXOR (DXR) CEO receives 30,000-share equity grant, now holds 243,694 - Stock Titan
Daxor (DXR) Chief Scientific Officer receives 25,000-share stock grant - Stock Titan
Daxor (DXR) director granted 2,500 stock options at $10.14 - Stock Titan
Daxor (DXR) director awarded 2,500 stock options at $10.14 strike - Stock Titan
DAXOR CORP (DXR) director receives 2,500 stock options at $10.14 strike - Stock Titan
DAXOR (DXR) director awarded 2,500 stock options at $10.14 strike price - Stock Titan
Daxor Shareholders Reelect Board and Ratify Auditor - The Globe and Mail
Daxor Corporation 8-K Filing June 2026: Shareholder Vote Results, Nasdaq Listing, and Company Details - Minichart
Daxor (NASDAQ: DXR) investors reelect full board and ratify Bush & Associates as auditor - Stock Titan
Number of shareholders of Daxor Corporation – BOATS:DXR - TradingView
Daxor Corporation (DXR) Holds Near Support After Modest DeclineAdaptive Moving Average - dars.gov.et
Discipline and Rules-Based Execution in DXR Response - Stock Traders Daily
Daxor (DXR) Proxy Filing Summary - Quartr
Daxor (DXR) Q4 2025 earnings summary - Quartr
Daxor (DXR) Q2 2024 earnings summary - Quartr
Daxor (DXR) Corporate Presentation Summary - Quartr
Daxor (DXR) Q4 2024 earnings summary - Quartr
Daxor Corp (DXR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Daxor Corp (DXR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Daxor Corp (DXR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Daxor Corp (DXR) Institutional Confidence - TradingKey
Daxor Corp (DXR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Daxor Corp (DXR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Daxor Corp (DXR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Daxor Corp (DXR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Daxor Corp (DXR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Behavioral Patterns of DXR and Institutional Flows - Stock Traders Daily
Daxor Corporation (DXR) Declines 4.39%: Approaching Key Support Near $10.07PCR Moving Average - newsline.com
Daxor Corporation (DXR) Q3 2007 Earnings: EPS Surges 325% Above Estimates, Stock Declines Despite Beat - newsline.com
Daxor (DXR) plans June 23, 2026 vote on directors and auditor - Stock Titan
Daxor (DXR) Proxy filing Summary - Quartr
Daxor (DXR) Secures Patent for Innovative Blood Volume Monitorin - GuruFocus
Daxor Corporation Azioni (DXR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Daxor Corporation Azioni (DXR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Michel Robert J | Chief Financial Officer |
Mar 31 '26 |
Buy |
9.90 |
1,000 |
9,900 |
21,050 |
1.24%
2.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):